Home > Quotes > OXFD

Oxford Immunotec Global PLC Ordinary Shares Quote & Summary Data

Get OXFD Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading OXFD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Oxford Immunotec Global PLC Ordinary Shares Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 10.61 $ 14.99
Low $ 10.38 $ 8.4515

The current last sale of $10.46 is 23.77% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. Our proprietary T-SPOTĀ®1 technology platform allows us to measure the responses of specific immune cells to inform the diagnosis, prognosis and monitoring of patients with immune-regulated conditions. Our current development activities are principally focused on four areas: chronic infections, transplantation, autoimmune and inflammatory disease and immune-oncology. We believe these areas are particularly attractive for the development of diagnostic tests because they involve large patient populations and chronic conditions that present the opportunity for both initial diagnosis and additional testing to monitor the conditions.  ... More ...  

Risk Grade

Where does OXFD fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?